SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 2.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $117,224 | -9.8% | 33,782 | +20.9% | 0.00% | – |
| Q2 2023 | $129,893 | -14.5% | 27,934 | -15.0% | 0.00% | – |
| Q1 2023 | $151,892 | -17.8% | 32,877 | +43.7% | 0.00% | – |
| Q4 2022 | $184,830 | +88.6% | 22,875 | +29.2% | 0.00% | – |
| Q3 2022 | $98,000 | -9.3% | 17,711 | -14.2% | 0.00% | – |
| Q2 2022 | $108,000 | -44.6% | 20,654 | -13.2% | 0.00% | – |
| Q1 2022 | $195,000 | -77.1% | 23,793 | -58.4% | 0.00% | – |
| Q4 2021 | $850,000 | -19.3% | 57,150 | +2.5% | 0.00% | – |
| Q3 2021 | $1,053,000 | +0.2% | 55,754 | -1.4% | 0.00% | -100.0% |
| Q2 2021 | $1,051,000 | -60.5% | 56,554 | -51.6% | 0.00% | 0.0% |
| Q1 2021 | $2,658,000 | +4.7% | 116,807 | -0.1% | 0.00% | -50.0% |
| Q4 2020 | $2,538,000 | +1674.8% | 116,894 | +726.0% | 0.00% | – |
| Q3 2020 | $143,000 | +123.4% | 14,152 | +72.1% | 0.00% | – |
| Q2 2020 | $64,000 | +88.2% | 8,223 | +143.4% | 0.00% | – |
| Q1 2020 | $34,000 | -58.5% | 3,379 | -55.3% | 0.00% | – |
| Q4 2019 | $82,000 | +228.0% | 7,559 | +164.1% | 0.00% | – |
| Q3 2019 | $25,000 | -75.0% | 2,862 | -67.9% | 0.00% | – |
| Q2 2019 | $100,000 | -4.8% | 8,906 | -4.7% | 0.00% | – |
| Q1 2019 | $105,000 | +20.7% | 9,349 | -4.7% | 0.00% | – |
| Q4 2018 | $87,000 | – | 9,815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |